KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Incyte (INCY) Operating Expenses (2016 - 2026)

Incyte filings provide 17 years of Operating Expenses readings, the most recent being $971.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 14.61% year-over-year to $971.6 million, compared with a TTM value of $3.8 billion through Mar 2026, down 11.52%, and an annual FY2025 reading of $3.6 billion, down 13.24% over the prior year.
  • Operating Expenses hit $971.6 million in Q1 2026 for Incyte, down from $1.2 billion in the prior quarter.
  • The five-year high for Operating Expenses was $1.5 billion in Q2 2024, with the low at $616.7 million in Q1 2022.
  • Median Operating Expenses over the past 5 years was $826.1 million (2023), compared with a mean of $862.8 million.
  • The sharpest move saw Operating Expenses skyrocketed 100.03% in 2024, then crashed 54.98% in 2025.
  • Year by year, Operating Expenses stood at $856.6 million in 2022, then dropped by 3.56% to $826.1 million in 2023, then grew by 6.19% to $877.2 million in 2024, then skyrocketed by 33.49% to $1.2 billion in 2025, then dropped by 17.03% to $971.6 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $971.6 million, $1.2 billion, and $922.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.